Clin2
NCT07861126Possibly a fitNot yet recruiting

Sovateltide for acute traumatic brain injury

Traumatic Brain Injury

Part of Brain & nervous system, Injuries & trauma clinical trials.

This study tests a drug called sovateltide given within 48 hours of a moderate to severe traumatic brain injury (TBI). The drug aims to improve recovery and brain function after injury.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
214 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are 18 to 90 years old
  • You have a moderate to severe closed head injury (not a penetrating wound like a gunshot)
  • Your first dose of the study drug can be given within 48 hours of the injury
  • A brain scan (CT) shows injury consistent with the study criteria
  • You have at least one pupil in your eye that reacts to light
  • You can receive the full course of treatment and attend follow-up visits

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05826912Enrolling by invitation· Phase 2
Testing new treatment for acute brain injury after a fall or hit

This study tests an investigational treatment to improve outcomes after a recent non-penetrating traumatic brain injury (like a fall or car crash). It uses early CT/MRI imaging and a blood test soon after injury to see who benefits and how well the treatment works.

San Francisco, California
NCT06701760Not yet recruiting· Phase 2
Testing a salt solution for severe traumatic brain injury

This trial tests giving a simple salt solution (sodium lactate) to people with severe traumatic brain injury. The goal is to see if it can reduce swelling and improve recovery.

NCT04602806Enrolling by invitation
Precision medicine study for traumatic brain injury

This study is looking at people with traumatic brain injuries to improve how they are treated. If you join, you will get an MRI and other tests within the first two days after your injury, and the researchers will track your recovery over time.

San Francisco, California
NCT07180277Recruiting· Phase 4
Steroid treatment for moderate to severe brain injury

This trial tests a steroid medicine called methylprednisolone to see if it can help people who have had a moderate to severe brain injury. It aims to reduce swelling in the brain and possibly improve recovery.

Suzhou, Jiangsu
NCT06790095Enrolling by invitation· Phase 2
Testing Cyclosporine for Moderate to Severe Brain Injury

This study tests a drug called cyclosporine to see if it can help people with moderate to severe traumatic brain injury. You may be eligible if you have a brain injury seen on CT and can start treatment within 24 hours.

San Francisco, California
NCT07358312Not yet recruiting
Steroids for brain swelling after head injury

This trial tests whether giving steroids can reduce brain swelling after a mild or moderate head injury. If you or a loved one had a brain injury within the last few days and the CT scan shows bruising, this study may offer extra treatment to help control swelling.

Hear when a new Traumatic Brain Injury trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.